Community pharmacists’ experiences with the new tapering program for benzodiazepines and Z-drugs in Belgium
The Belgian pilot program has been positively received by CPs. Success factors are the interdisciplinary collaboration (social influences) and the specific elements of the program itself (environmental context and resources). To better understand the factors influencing participation, a qualitative in-depth exploration of CPs, GPs and patients perspectives of the tapering program is recommended. Furthermore, implementation outcomes, the sustainability of BZRA cessation and the benefits patients experience from discontinuation need to be investigated.
Authors
- Thierry Christiaens (ORCID: https://orcid.org/0000-0003-4064-2908)
- Ellen Van Leeuwen (ORCID: https://orcid.org/0000-0002-3155-4095)
- Koen Boussery (ORCID: https://orcid.org/0000-0003-2582-5044)
- Mirko Petrović (ORCID: https://orcid.org/0000-0002-7506-8646)
- Els Mehuys (ORCID: https://orcid.org/0000-0003-1848-208X)
- Florian Stul (ORCID: https://orcid.org/0000-0002-9329-4479)
- Lies Vanderbeken (ORCID: https://orcid.org/0009-0002-9829-6227)
- Laura Lejeune
Institutions
- Ghent University Hospital (BE)
- Ghent University (BE)
Publication Details
- Journal
- Acta Clinica Belgica
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/17843286.2025.2572344
- Citations
- 1
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.12